stockrowThe Cooper Companies, Inc. (COO) vs Repligen Corporation (RGEN)
- The Cooper Companies, Inc. COO 63.44 −1.52%
- Repligen Corporation RGEN 169.01 −5.16%
The Cooper Companies, Inc. and Repligen Corporation are both Medical Instruments & Supplies companies. The Cooper Companies, Inc. is the larger, with a market value of $12.1B against $10.8B — 1.1× the size. Repligen Corporation has negative trailing earnings, so its P/E is not meaningful; The Cooper Companies, Inc. trades at 21.7×. Repligen Corporation grew revenue faster over the last twelve months: 13.8% against 4.73%. The Cooper Companies, Inc. has the higher net margin (13.5% vs −1.47%) and the higher return on invested capital (3.17% vs 0.64%). Across the 21 metrics below, The Cooper Companies, Inc. leads on 15 and Repligen Corporation on 6.
Valuation
Profitability
| Metric | COO | RGEN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 65.93% | 53.46% | 53.60% |
| Operating margin | 12.84% | 2.26% | 1.97% |
| Net margin | 13.46% | (1.47%) | 0.00% |
| Free cash flow margin | 16.00% | 13.09% | 2.36% |
| Return on equity | 6.84% | (0.57%) | 0.00% |
| Return on assets | 4.55% | (0.40%) | 0.00% |
| Return on invested capital | 3.17% | 0.64% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack